Harnessing Metabolomics to Advance Epilepsy Research. Issue 2 (March 2022)

• Record Type: Journal Article
• Authors: Eid, Tore
• Is Part Of: Epilepsy currents. Volume 22:Issue 2(2022)
• Page Start: 123
• Page End: 129
• Publication Date: 2022-03
• Subjects: biomarkers -- chromatography -- epileptogenesis -- mass spectrometry -- metabolomics -- seizure forecasting; Epilepsy -- Periodicals; 616.853005
• DOI: 10.1177/15357597221074518
• Languages: English
• ISSNs: 1535-7597

Abstract

Metabolomics is the laboratory analysis and scientific study of the metabolome—that is, the entire collection of small molecule chemicals in an organism. The metabolome represents the functional state of an organism and provides a multifaceted readout of the aggregate activity of endogenous (cellular) and exogenous (environmental) processes. In this review, we discuss how the integrative and dynamic properties of the metabolome create unique opportunities to study complex pathologies that evolve and oscillate over time, like epilepsy. We explain how the scientific progress and clinical applications of metabolomics remain hampered by biological and technical challenges, and we propose best practices to overcome these challenges so that metabolomics can be used in a rigorous and effective manner to further epilepsy research.